Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| EXPO | 8-K | bullish | 6/10 | Exponent reported Q3 2026 revenue of $173.7M (up 18% YoY) and GAAP diluted EPS of $0.64 (up from $0.55), both above cons | Oct 29, 2026 |
| AMZN | 8-K | bullish | 6/10 | Amazon reported Q3 2026 net sales of $201.9B (+12% YoY) and operating income of $28.1B (+61% YoY), with operating margin | Oct 29, 2026 |
| FORR | 8-K | neutral | 5/10 | Forrester Research reported Q3 2026 adjusted EPS of $0.24, beating the $0.20 consensus, on revenue of $86.1M which also | Oct 29, 2026 |
| COLM | 8-K | bullish | 6/10 | Columbia Sportswear reported Q3 2026 net sales of $962.6M (+2% YoY) and diluted EPS of $1.66, exceeding consensus estima | Oct 29, 2026 |
| HR | 8-K | bullish | 5/10 | Healthcare Realty reported Q3 2026 Normalized FFO of $0.42 per share, in line with the $0.41 consensus, and raised full- | Oct 29, 2026 |
| NPV | 425 | neutral | 3/10 | Nuveen Virginia Quality Municipal Income Fund (NPV) filed a Rule 425 communication urging shareholders to vote on the pr | Oct 29, 2026 |
| TACH | 425 | neutral | 3/10 | OpenPayd Global Holdings filed a Rule 425 communication containing a transcript of a CEO interview at Money20/20 USA dis | Oct 29, 2026 |
| SEGG | 25-NSE | neutral | 3/10 | Nasdaq filed a Form 25-NSE to remove SEGG's warrants from listing and registration, effective immediately, because the w | Oct 29, 2026 |
| STOK | 8-K | neutral | 5/10 | Stoke Therapeutics reported Q3 2026 results with revenue of $11.3M (above the $8.2M consensus) and a GAAP net loss of $1 | Oct 29, 2026 |
| SPOK | 8-K | bearish | 5/10 | Spok Holdings filed an 8-K posting an investor presentation on its website. The presentation reports Q3 2026 financial r | Oct 29, 2026 |
| IRS | 6-K | neutral | 3/10 | IRSA signed a barter agreement for a lot in the Ramblas del Plata project valued at approximately USD 8.75 million, paid | Oct 29, 2026 |
| BHVN | 8-K | bullish | 7/10 | Biohaven reported Q3 2026 results with a net loss of $129.3M ($0.86 GAAP EPS), narrower than the $173.4M loss in Q3 2025 | Oct 29, 2026 |
| PDEX | 8-K | neutral | 5/10 | Pro-Dex reported fiscal Q1 2027 revenue of $20.6M, up 11% YoY and slightly above the $20.4M consensus. GAAP diluted EPS | Oct 29, 2026 |
| GS | CLUSTER | bearish | 4/10 | CEO David Solomon sold $8.36M in open-market shares on October 27, 2026, and Chief Administrative Officer Ericka Leslie | Oct 29, 2026 |
| ENVA | 144 | neutral | 2/10 | Sean Rahilly, an officer of Enova International, filed a Form 144 on October 29, 2026, indicating intent to sell 10,000 | Oct 29, 2026 |
| MMSI | PRESS-RELEASE | neutral | 4/10 | Merit Medical Systems acquired all remaining equity of Solo Pace for approximately $45 million, adding temporary pacing | Oct 29, 2026 |
| PRTA | 8-K | bearish | 6/10 | Bristol Myers Squibb terminated the PRX019 global license agreement after an internal strategic review, deciding not to | Oct 29, 2026 |
| FLOC | 144 | neutral | 2/10 | Former officer Chad Roberts filed a Form 144 notice of intent to sell 4,375 shares of Flowco Holdings common stock, with | Oct 29, 2026 |
| GILD | 8-K | bullish | 6/10 | Gilead reported Q3 2026 product sales of $8.3B (+13% YoY) and non-GAAP EPS of $2.55, beating the $2.19 consensus. Base b | Oct 29, 2026 |
| DXCM | 8-K | bullish | 6/10 | Dexcom reported Q3 2026 revenue of $1.344B (up 11% YoY), above the $1.33B consensus, and non-GAAP EPS of $0.73, above th | Oct 29, 2026 |
| SPGI | 144 | neutral | 2/10 | Steven J. Kemps, an officer of S&P Global Inc., filed a Form 144 on October 29, 2026, indicating intent to sell 2,794 sh | Oct 29, 2026 |
| MVBF | 8-K | neutral | 4/10 | MVB Financial Corp. filed an 8-K furnishing an investor presentation for Q3 2026. The presentation highlights strong yea | Oct 29, 2026 |
| SYM | PRESS-RELEASE | bullish | 6/10 | Symbotic announced an expanded commercial agreement with Walmart to bring additional automation capabilities to 25 U.S. | Oct 29, 2026 |
| MSTR | 8-K | neutral | 6/10 | Strategy Inc reported Q3 2026 operating income of $20.91 billion and diluted EPS of $44.75, driven by a $20.91 billion g | Oct 29, 2026 |
| DYNC | 25-NSE | bearish | 7/10 | Nasdaq filed a Form 25-NSE to remove Dynamix Corp's securities from listing and registration, effective immediately. The | Oct 29, 2026 |
| FSLR | 8-K | bearish | 6/10 | First Solar reported Q3 2026 net sales of $1.23B, down 23% YoY, but GAAP diluted EPS of $5.30 beat the $4.64 consensus. | Oct 29, 2026 |
| NMS | 425 | neutral | 3/10 | Nuveen Minnesota Quality Municipal Income Fund (NMS) filed a Rule 425 communication urging shareholders to vote in favor | Oct 29, 2026 |
| CACC | PRESS-RELEASE | bearish | 6/10 | Credit Acceptance reported Q3 2026 adjusted EPS of $13.01, beating the $12.34 consensus by 5.4%, while GAAP net loss was | Oct 29, 2026 |
| CACC | 8-K | bearish | 6/10 | Credit Acceptance reported a GAAP net loss of $56.6 million for Q3 2026, versus net income of $108.2 million a year ago, | Oct 29, 2026 |
| BBIO | 8-K | bullish | 6/10 | BridgeBio reported Q3 2026 total revenues of $353.2M, up 193% YoY from $120.7M, driven by $253.2M in U.S. Attruby net pr | Oct 29, 2026 |